JB Chemicals & Pharmaceuticals has received approval for its Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (US FDA) for Loratadine Tablets USP 10 mg (for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy) for over-the-counter (OTC) use. This product is generic version of Clarting tablet in the same strength of Bayer Healthcare LLC. The Company expects to commercialize this product in Q1 of FY 2021-22 and is expected to improve Company's US sales.
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
